Search for pathway correlated target
You are searching for: hsa04360
T12808 Target Info |
Target Name | Protein kinase C alpha (PRKCA) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Spinal muscular atrophy; Renal transplantation; | ||
Drugs | Sodium phenylbutyrate | Drug Info |
T15023 Target Info |
Target Name | Neuropilin-1 (NRP1) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Neovascular age-related macular degeneration; Solid tumour/cancer; | ||
Drugs | Pegaptanib | Drug Info |
T92078 Target Info |
Target Name | Dihydropyrimidinase related protein 2 (DPYSL2) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Convulsion; Epilepsy; | ||
Drugs | Lacosamide | Drug Info |
T51282 Target Info |
Target Name | Rho-associated protein kinase 1 (ROCK1) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Open-angle glaucoma; Diabetic nephropathy; | ||
Drugs | Netarsudil | Drug Info |
T70977 Target Info |
Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Myotonic dystrophy; Acute myeloid leukaemia; | ||
Drugs | AMO-02 | Drug Info |
T49507 Target Info |
Target Name | Ephrin type-B receptor 4 (EPHB4) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Recurrent glioblastoma; Polycystic kidney disease; | ||
Drugs | KD019 | Drug Info |
T58970 Target Info |
Target Name | Extracellular signal-regulated kinase 2 (ERK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Artery stenosis; | ||
Drugs | BVD-523 | Drug Info |
T73756 Target Info |
Target Name | Ephrin type-B receptor 2 (EPHB2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Kaposi sarcoma; Melanoma; | ||
Drugs | BVD-523 | Drug Info |
T15068 Target Info |
Target Name | Focal adhesion kinase 1 (FAK) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Ovarian cancer; Mesothelioma; | ||
Drugs | VS-6063 | Drug Info |
T01851 Target Info |
Target Name | Integrin beta-1 (ITGB1) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Non-small-cell lung cancer; Glioblastoma of brain; | ||
Drugs | 131I-radretumab | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.